Newsletter | January 16, 2024

01.16.24 -- A Patient-Centric Approach Built On The Porosome

FEATURED EDITORIAL

A Patient-Centric Approach Built On The Porosome

By Guillermo “Gil” Marmol, Porosome Therapeutics, Inc.

About 85% of disease-causing proteins remain impervious to current therapeutic interventions. One potential pathway to address this problem: the porosome.

Pacesetters Are Product Innovators Who Embrace Digital Process Enhancement

A conversation with Jordan Schmitting, senior research analyst, The Josh Bersin Company

The Josh Bersin Company recently underwent research examining pharma/biotech “pacesetters” in the field. We caught up with Jordan Schmitting, senior research analyst at The Josh Bersin Company, to discuss the trends illuminated by the research.

INDUSTRY INSIGHTS

Rapid Development Of Amorphous Solid Dispersions For Bioavailability

Webinar | Lonza

See how an amorphous solid dispersion (ASD) of acalabrutinib was designed using in vitro studies and in silico modeling. Understand how ASD formulations can enhance bioavailability.

Empowering A New Era Of Patient-Centric Medicines

Podcast | Nanoform

Discover the challenges pharma companies are facing as they switch focus as well as the actions and technologies companies are implementing to help achieve a brighter future for patients.

Solving The Analytics Bottleneck In Cell Line Development

Webinar | Sartorius

Discover a fully automated, benchtop, walk-away system for accelerated and efficient cell culture sample preparation. Learn how this system clarifies and purifies mAbs in one step without sacrificing quality.

Predictive Modeling Of Concentration-Dependent Viscosity Behavior

Webinar | Lonza

Review a modeling approach employing artificial neural networks using experimental factors combined with simulation-derived parameters plus viscosity data from 27 highly concentrated mAbs.

SPONSOR

Participate In BioPlan’s 21st Annual Biopharma Manufacturing Study!

Ensure your voice is included in the bioindustry's most authoritative, comprehensive analysis! Be the first to receive this year's industry benchmarking, and more! For each completed survey, BioPlan will either send a $35 Amazon e-gift card or donate up to $3,000 to global health charities. Participate now .